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Abstract
Introduction: The potential effects of amalgam fillings on the development of Alzheimer’s disease (AD) are not
well understood. The aim of the study was to evaluate the association between dental amalgam fillings and
Alzheimer’s disease in Taiwanese population aged 65 and older.
Methods: Data were retrieved from the Longitudinal Health Insurance Database (LHID 2005 and 2010). The study
enrolled 1,943,702 beneficiaries from the LHID database. After excluding death cases and individuals aged 65 and under,
207,587 enrollees were finally involved in the study. Dental amalgam fillings are coded as 89001C, 89002C, 89003C,
89101C, 89102C, or 89103C in the national health insurance research database (NHIRD). Alzheimer’s disease was
diagnosed using the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) codes 331.0.
Results: Individuals exposed to amalgam fillings had higher risk of Alzheimer’s disease (odds ratio, OR = 1.105, 95 %
confidence interval, CI = 1.025-1.190) than their non-exposed counterparts. Further analysis showed that the odds ratio
of Ahlzheimer's disease was 1.07 (95 % CI = 0.962-1.196) in men and 1.132 (95 % CI = 1.022-1.254) in women.
Conclusions: Women who were exposed to amalgam fillings were 1.132 times more likely to have Alzheimer’s disease
than were their non-exposed counterparts.
Introduction
Dental amalgam, a material for filling prepared cavities
after removing caries, consists of about 50 % mercury [1].
Mercury vapor has been proven to be toxic to the central
nervous system. In 2008, the European Commission
asserted that there is no evidence showing negative effects
on the human central nervous system when applying
amalgam fillings as reported in previous studies. In 2009,
a similar statement was made by the American Dental
Association [2, 3]. The United States Food and Drug
Administration, however, stated in 2008 that mercury in
amalgam can increase neural risk in children and pregnant
women [4]. Some scientific experiments showed that
amalgam restorations in the oral cavity keep releasing
human-absorbable mercury vapor [5–8]. Other studies
have reported significant associations between mercury
concentration in urine or in blood and quantities of amal-
gam restoration or number of total faces in amalgam res-
toration [9–11]. Furthermore, occupational studies on
mercury exposure provided a strong association between
mercury metal and the degeneration of the nervous sys-
tem [12]. Inorganic mercury chloride (HgCl2) at 0.025 to
25 μM has been associated with both neuronal degener-
ation and perturbed excitability [13]. Hock and colleagues
have reported a two-fold increase in mercury levels among
patients with Alzheimer’s disease (AD) when compared to
control counterparts [14]. The influence of mercury on AD
is not well understood. However, it has been demonstrated
that mercury can dramatically promote heparin–induced
aggregation of R2, the Alzheimer’s tau fragment [15].
AD has been regarded as an unsolved, irreversible, and
incurable brain neuron degeneration. AD patients nor-
mally have difficulties retrieving memory. They exhibit
behavioral change as the disease progresses. Eventually,
the disease leads to loss of control of body functions
[16–18]. Being the most common type of dementia, AD
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is most often diagnosed in individuals 65-years old and
older [19]. One study reported that in 2006, the world-
wide prevalence of Alzheimer's disease was 22.6 million
while it has been predicted that by 2050, 1 in 85 people
will suffer from AD [20]. From 2000–2010, someone in
America was reported with AD every 68 s. Deaths due
to AD were reported at 68 % while those resulting from
heart diseases were observed to have decreased [21]. Ac-
cording to the Taiwan Alzheimer’s Disease Association,
an estimated 3.5 % of Taiwanese will suffer from demen-
tia by 2050. AD, the most common type of dementia, is
of critical importance in public health. The Alzheimer’s
Association in the USA claimed there is no association be-
tween silver dental fillings (known as amalgam fillings)
and AD [22]. However, the impact of amalgam fillings on
the development of AD is not well understood [23, 24].
Aging is considered to be a major risk factor for AD
[25, 26]. This study aimed to investigate the association
between dental amalgam fillings and AD in the Taiwanese
population 65-years and older.
Methods
The study was conducted using the Longitudinal Health
Insurance Databases (LHID 2005 and 2010). The data-
bases comprise secondary data released to the public for
research purposes; hence, this study was exempted from
full review by the Institutional Review Board. Subjects
included citizens who were ≥ 65 years at study end in
2010. The basic characteristics of the study subjects in-
cluded births, gender and income. Dental amalgam fill-
ings were coded as 89001C, 89002C, 89003C, 89101C,
89102C, and 89103C in the national health insurance re-
search database (NHIRD), where 89001C indicates
single-face amalgam restoration, 89002C indicates two-
face amalgam restoration, and 89003C indicates three-
face amalgam restoration. The following codes, 89101C,
89102C, and 89103C, represent single-surface, two- and
three-surface amalgam restoration in specific cases. Indi-
viduals with AD were diagnosed using International
Classification of Diseases, Ninth Revision, Clinical Modi-
fication (ICD-9-CM) code 331.0.
Data analyses were performed using the SAS 9.3 soft-
ware package (SAS Institute Inc., Cary, NC, USA). Mul-
tiple logistic regression analysis was used to estimate the
association between dental amalgam fillings and AD. The
number of times and accumulated faces that a patient re-
ceived amalgam fillings during 2001–2010 were regarded
as independent variables while AD was considered as the
dependent variable. Adjustments were made for age,
gender, income, and residential region.
Fig. 1 Flow chart showing amalgam fillings and Alzheimer’s disease (2000–2010)
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Results
In total, 207,587 individuals 65-years old and above were
analyzed (Fig. 1). Generally, 2.76 % of men exposed to
amalgam fillings and 2.8 % of their unexposed counter-
parts were diagnosed with AD as were 2.73 % of women
exposed to amalgam fillings and 2.93 % of their unexposed
counterparts. Table 1 shows the demographic characteris-
tics of individuals with and without AD. The mean age of
individuals with AD was significantly higher than of those
with no AD (79.36 ± 7.14 vs. 74.87 ± 6.89, p < 0.001). There
was no significant difference in the gender distributions of
AD. Subjects with and without AD were categorized into
four levels by income. The percentages of subjects with
AD were 41.86, 25.70, 31.59, and 0.85 % by income ran-
ging from 1–20,000, 20,001-40,000, and >40,000 respect-
ively. Income distributions were significantly different
among AD and non-AD individuals. Central, South and
Taipei regions had high prevalences of the disease. Indi-
viduals exposed to amalgam fillings had a higher risk of
Alzheimer’s disease [odds ratio (OR) = 1.105, 95 % confi-
dence interval (CI) = 1.025-1.190] after adjusting for age,
gender, income, and residential region (Table 2). Further
analysis was made to assess disease risks by gender. The
ORs for AD were 1.07 (95 % CI = 0.962-1.196) in men and
1.132 (95 % CI = 1.022-1.254) in women (Table 3).
Discussion
This is the first study to investigate the association be-
tween dental amalgam fillings and AD disease using
large-scale data. The study results show that women ex-
posed to mercury amalgam fillings were 1.132 times
more likely to have Alzheimer’s disease than were their
non-exposed counterparts. These findings are similar to
those of previous studies that have reported elevated
levels of plasma mercury in subjects with AD in com-
parison with their healthy controls [14, 27]. Moreover,
mercury has been suggested as an important toxic elem-
ent in AD [28]. Since the launching of the National
Health Insurance (NHI) in Taiwan, the coverage rate
was 97 % by 2001 and 99 % by 2009 [29, 30]. The NHI
has been responsible for the payment of amalgam fillings
since 2004. The association between amalgam fillings
and AD may have been underestimated considering that
the number of amalgam fillings from 2001–2010 may
not represent the actual fillings during the patients’ life-
times. However, people who had multiple amalgam fillings
from 2001–2010 were more likely to have subsequent fill-
ings. The NHIRD contains dental records of every benefi-
ciary limited to 2001 ~ 2010. Regarding the individuals
without dental amalgam fillings, it is possible that this pa-
tient group may have had amalgam fillings earlier in their
Table 1 Baseline characteristics of study subjects
Variable Alzheimer’s disease No Alzheimer’s disease p-value
(n = 5,906) (n = 201,681)
No. % No. %
Age (year) 79.36 ± 7.14 74.87 ± 6.89 <.0001
Sex 0.1496
Men 2,755 46.65 95,995 47.60
Women 3,151 53.35 105,686 52.40
Income (NT$) <.0001
Dependent 2,472 41.86 84,740 42.02
1–20,000 1,518 25.70 44,260 21.95
20,001-40,000 1,866 31.59 69,890 34.65
>40,000 50 0.85 2,791 1.38
Region <.0001
Area 1(Taipei) 1,659 28.09 65,573 32.51
Area 2 (Northern) 868 14.70 26,761 13.27
Area 3 (Central) 1256 21.27 36,693 18.19
Area 4 (Southern) 1,247 21.11 34,690 17.20
Area 5 (Kao-Ping) 739 12.51 32,141 15.94
Area 6 (Eastern) 137 2.32 5,823 2.89
Amalgam filling 0.2274
None 5,046 85.44 171,162 84.87
Yes 860 14.56 30,519 15.13
Age was mean ± S.E
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life, and before 2001, removed them or replaced them
with other dental materials, such as gold alloys or ceram-
ics. There are also root filled teeth in jaws. Some root fill-
ings, especially the retrograde root fillings, often contain
mercury amalgam. In this study, the control group was
not a “pure” non-exposure group because its individuals
may have been exposed before 2001. Of course, prior to
2001, exposure to amalgam fillings might have either been
lesser or greater in the exposure than the non-exposure
group, and vice versa. This also applies for replacements
with other dental materials, such as gold alloys or ceram-
ics. However, there may have been non-differential mis-
classification at baseline which might have resulted in
underestimation. From our findings, however, the results
are significant implying higher risk of exposure. Even
though the NHIRD could not provide complete informa-
tion on the exact number of fillings and AD, amalgam fill-
ings from 2001–2010 could equally be representative of
the total number of fillings during a patient’s life. The
same assumption was made for accumulated faces. Accu-
mulated faces are the sum of the number of faces of each
amalgam filling .
AD is often diagnosed among older people. This ex-
plains why subjects 65-years old and above were used in
this study. Molecular lesions have been observed in
more than 80 % of senile AD brains [31]. A study
showed that low income predicts the risk of developing
incident AD [31]; hence, income was adjusted in this
study. Environmental pollutants, such as heavy metal
contaminations in ground water, contribute to varying
levels of dietary mercury. Residential regions were ad-
justed because higher concentrations of mercury have
been reported in western townships [32].
In this study, it is assumed that mercury released from
amalgams would initiate AD. However, it would also be
possible that oral exposure to nickel, palladium, chro-
mium or cobalt might also be a cause of AD. Some
people who visit the dentist might have a higher chance
of getting amalgam restorations but also of getting cast
restorations, such as crowns or bridges. In Asian coun-
tries nickel-based alloys are often used for this treat-
ment. However, the National Health Insurance Database
does not provide data on crowns and bridges partly be-
cause they are considered as advanced prosthodontic
treatments for both esthetics and function. Moreover,
Table 2 Logistic regression analysis of factors associated with
Alzheimer’s disease
Variable Logistic regression model














Area 1 (Taipei) 0.735 0.675-0.800
Area 2 (Northern) 1.000 -
Area 3 (Central) 1.127 1.032-1.232
Area 4 (Southern) 1.226 1.120-1.341
Area 5 (Kao-Ping) 0.734 0.672-0.821
Area 6 (Eastern) 0.732 0.609-0.880
Odds ratio was adjusted for age, gender, insurance level, and residential region
OR odds ratio, CI confidence interval
Table 3 Characteristics of people with amalgam fillings in
both genders
Variable Logistic regression model
Men Women
OR 95 % CI OR 95 % CI
Amalgam fillings
No 1.00 - 1.00 -
Yes 1.07 0.962-1.196 1.132 1.022-1.254
Age 1.09 1.084-1.096 1.085 1.080-1.090
Income (NT$)
Dependent 1.278 1.156-1.413 1.455 1.335-1.585
1–20,000 1.162 1.052-1.284 1.452 1.297 -1.625
20,001-40,000 1.00 - 1.00 -
>40,000 0.945 0.656-1.360 1.770 1.113-2.815
Region
Area 1a 0.838 0.740-0.950 0.650 0.579-0.730
Area 2b 1.00 - 1.00 -
Area 3c 1.302 1.142-1.484 0.991 0.878-1.118
Area 4d 1.409 1.234-1.610 1.087 0.963-1.228
Area 5e 0.801 0.692-0.929 0.695 0.606-0.796
Area 6f 0.881 0.685-1.134 0.611 0.466-0.800
Odds ratio was adjusted for age, income, and residential region
aArea 1 (Taipei): Taipei City and County, Yilan County, Keelung City, Kinmen
County, and Lienhiang County)
bArea 2 (Northern): Taoyuan County, Hsinchu County, Miaoli County, and
Hsinchu City
cArea 3 (Central): Taichung City, Taichung County, Changhua County, and
Nantou County
dArea 4 (Southern): Tainan City and County, Chiayi City and County, Yunlin County
eArea 5 (Kao-Ping): Kaohsiung City and County, Pingtung County, Penghu County
fArea 6 (Eastern): Hualin and Taitung County
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they are more costly than amalgam restorations. The
authors believe that crowns and bridges are a concern
yet are less critical than amalgam restoration due to
the following reasons: (1) The frequency of getting
crowns and bridges is lower compared to amalgam
usage. Amalga is indicated when early caries are
present. Crowns are indicated when the tooth struc-
ture is severely destroyed possibly due to severe caries
while bridges are indicated in edentulous areas. (2)
Most of the crowns and bridges are porcelain-fused-
metal. That is, they are covered by porcelain with a
natural-tooth-like look. The degree of metal exposure
to the oral cavity is less. Even with all-metal crowns
and bridges, the surfaces of the prosthesis are highly
polished to decrease the abrasion of the metals.
Therefore, effects due to oral exposure to nickel, pal-
ladium, chromium or cobalt were possibly minimized.
Conclusions
After adjusting for age, income and residential region,
women exposed to mercury amalgam fillings were 1.132
times more likely to have AD than were their non-
exposed counterparts.
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